BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37480846)

  • 1. Nucleocytoplasmic mRNA redistribution accompanies RNA binding protein mislocalization in ALS motor neurons and is restored by VCP ATPase inhibition.
    Ziff OJ; Harley J; Wang Y; Neeves J; Tyzack G; Ibrahim F; Skehel M; Chakrabarti AM; Kelly G; Patani R
    Neuron; 2023 Oct; 111(19):3011-3027.e7. PubMed ID: 37480846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 and FUS mislocalization in VCP mutant motor neurons is reversed by pharmacological inhibition of the VCP D2 ATPase domain.
    Harley J; Hagemann C; Serio A; Patani R
    Brain Commun; 2021; 3(3):fcab166. PubMed ID: 34396115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress-Specific Spatiotemporal Responses of RNA-Binding Proteins in Human Stem-Cell-Derived Motor Neurons.
    Harley J; Patani R
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mutations in the ALS gene CCNF cause cytoplasmic mislocalization of Cyclin F and elevated VCP ATPase activity.
    Yu Y; Nakagawa T; Morohoshi A; Nakagawa M; Ishida N; Suzuki N; Aoki M; Nakayama K
    Hum Mol Genet; 2019 Oct; 28(20):3486-3497. PubMed ID: 31577344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA polymerase II-associated proteins reveal pathways affected in VCP-related amyotrophic lateral sclerosis.
    Rafiee MR; Rohban S; Davey K; Ule J; Luscombe NM
    Brain; 2023 Jun; 146(6):2547-2556. PubMed ID: 36789492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant cytoplasmic intron retention is a blueprint for RNA binding protein mislocalization in VCP-related amyotrophic lateral sclerosis.
    Tyzack GE; Neeves J; Crerar H; Klein P; Ziff O; Taha DM; Luisier R; Luscombe NM; Patani R
    Brain; 2021 Aug; 144(7):1985-1993. PubMed ID: 33693641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS.
    Liu YJ; Kuo HC; Chern Y
    Neurobiol Dis; 2021 Dec; 160():105531. PubMed ID: 34634461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent mRNA localization defects and cell death in ALS neurons caused by transient cellular stress.
    Markmiller S; Sathe S; Server KL; Nguyen TB; Fulzele A; Cody N; Javaherian A; Broski S; Finkbeiner S; Bennett EJ; Lécuyer E; Yeo GW
    Cell Rep; 2021 Sep; 36(10):109685. PubMed ID: 34496257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients.
    Bennett CL; Dastidar SG; Ling SC; Malik B; Ashe T; Wadhwa M; Miller DB; Lee C; Mitchell MB; van Es MA; Grunseich C; Chen Y; Sopher BL; Greensmith L; Cleveland DW; La Spada AR
    Acta Neuropathol; 2018 Sep; 136(3):425-443. PubMed ID: 29725819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocytes of patients with amyotrophic lateral sclerosis linked to gene mutations display altered TDP-43 subcellular distribution.
    De Marco G; Lomartire A; Calvo A; Risso A; De Luca E; Mostert M; Mandrioli J; Caponnetto C; Borghero G; Manera U; Canosa A; Moglia C; Restagno G; Fini N; Tarella C; Giordana MT; Rinaudo MT; Chiò A
    Neuropathol Appl Neurobiol; 2017 Feb; 43(2):133-153. PubMed ID: 27178390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutant.
    Ayaki T; Ito H; Fukushima H; Inoue T; Kondo T; Ikemoto A; Asano T; Shodai A; Fujita T; Fukui S; Morino H; Nakano S; Kusaka H; Yamashita H; Ihara M; Matsumoto R; Kawamata J; Urushitani M; Kawakami H; Takahashi R
    Acta Neuropathol Commun; 2014 Dec; 2():172. PubMed ID: 25492614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of proteome-wide degradation dynamics in ALS SOD1 iPSC-derived patient neurons reveals disrupted VCP homeostasis.
    Tsioras K; Smith KC; Edassery SL; Garjani M; Li Y; Williams C; McKenna ED; Guo W; Wilen AP; Hark TJ; Marklund SL; Ostrow LW; Gilthorpe JD; Ichida JK; Kalb RG; Savas JN; Kiskinis E
    Cell Rep; 2023 Oct; 42(10):113160. PubMed ID: 37776851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients.
    Yamashita T; Kwak S
    Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ALS-linked mutation in TDP-43 disrupts normal protein interactions in the motor neuron response to oxidative stress.
    Feneberg E; Gordon D; Thompson AG; Finelli MJ; Dafinca R; Candalija A; Charles PD; Mäger I; Wood MJ; Fischer R; Kessler BM; Gray E; Turner MR; Talbot K
    Neurobiol Dis; 2020 Oct; 144():105050. PubMed ID: 32800996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic variants of Valosin-containing protein induce lysosomal damage and transcriptional activation of autophagy regulators in neuronal cells.
    Ferrari V; Cristofani R; Cicardi ME; Tedesco B; Crippa V; Chierichetti M; Casarotto E; Cozzi M; Mina F; Galbiati M; Piccolella M; Carra S; Vaccari T; Nalbandian A; Kimonis V; Fortuna TR; Pandey UB; Gagliani MC; Cortese K; Rusmini P; Poletti A
    Neuropathol Appl Neurobiol; 2022 Aug; 48(5):e12818. PubMed ID: 35501124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
    Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
    Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
    Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive Motor Neuron Pathology and the Role of Astrocytes in a Human Stem Cell Model of VCP-Related ALS.
    Hall CE; Yao Z; Choi M; Tyzack GE; Serio A; Luisier R; Harley J; Preza E; Arber C; Crisp SJ; Watson PMD; Kullmann DM; Abramov AY; Wray S; Burley R; Loh SHY; Martins LM; Stevens MM; Luscombe NM; Sibley CR; Lakatos A; Ule J; Gandhi S; Patani R
    Cell Rep; 2017 May; 19(9):1739-1749. PubMed ID: 28564594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FUS is lost from nuclei and gained in neurites of motor neurons in a human stem cell model of VCP-related ALS.
    Harley J; Hagemann C; Serio A; Patani R
    Brain; 2020 Dec; 143(12):e103. PubMed ID: 33253377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.